The co-founder of Regeneron has warned that blockbuster weight-loss drugs could cause “more harm than good ... and Wegovy maker Novo Nordisk and Eli Lilly, the company behind Mounjaro and Zepbound.

The wife of the country singer took a small dose of tirzepatide, a weight loss drug commonly used to treat diabetes ...

Jelly Roll's wife Bunnie XO said she got sick and "s--t my brains out" after "microdosing" the weight loss drug tirzepatide, ...

Jelly Roll's wife Bunnie XO said she got sick and "s--t my brains out" after "microdosing" the weight loss drug tirzepatide, which is often marketed as Mounjaro or Zepbound.

Americans who turned to telehealth companies and compounding pharmacies for cheap versions of Eli Lilly & Co.’s weight-loss ...

The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...

Newly released data shows that the U.S. may have reached peak obesity in 2020 — and the timing unsurprisingly coincides with ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 569.58% and ...

The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...

Ozempic and similar drugs are often effective because they produce feelings of satisfaction, in line with the NBC theory of ...

NHS England plans a phased rollout of tirzepatide to treat severe obesity, with early trials showing significant weight loss.